These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 2532380)
21. Asbestos and the pleura: a review. Cugell DW; Kamp DW Chest; 2004 Mar; 125(3):1103-17. PubMed ID: 15006974 [No Abstract] [Full Text] [Related]
22. Histological findings and lung dust analysis as the basis for occupational disease compensation in asbestos-related lung cancer in Germany. Feder IS; Theile A; Tannapfel A Int J Occup Med Environ Health; 2018 Jan; 31(3):293-305. PubMed ID: 29099505 [TBL] [Abstract][Full Text] [Related]
24. The social context of occupational disease: asbestos and South Africa. Myers J Int J Health Serv; 1981; 11(2):227-45. PubMed ID: 6453847 [TBL] [Abstract][Full Text] [Related]
25. [Clinical and hygienic aspects of asbestos-induced lung diseases]. Kalmaev KK; Kaptsov VA Gig Sanit; 2000; (2):55-7. PubMed ID: 10769972 [TBL] [Abstract][Full Text] [Related]
26. [Asbestos in France]. Frija J; Fournier M Rev Mal Respir; 2007 Jun; 24(6):687-9. PubMed ID: 17632429 [No Abstract] [Full Text] [Related]
27. Evaluation for compensation of asbestos-exposed individuals. II. Apportionment of risk for lung cancer and mesothelioma. Chase GR; Kotin P; Crump K; Mitchell RS J Occup Med; 1985 Mar; 27(3):189-98. PubMed ID: 3156981 [TBL] [Abstract][Full Text] [Related]
28. Diagnosis of asbestos-related pleuropolmonary diseases. Governa M; Amati M; Bellis D; Bichisecchi E; Santarelli L Med Lav; 2006; 97(3):463-74. PubMed ID: 17009682 [TBL] [Abstract][Full Text] [Related]
29. Lung cancer latency and asbestos liability. Mustacchi P J Leg Med; 1996 Jun; 17(2):277-300. PubMed ID: 8691057 [No Abstract] [Full Text] [Related]
30. [The effectiveness of compensation system for mesotheliomas due to occupational exposure to asbestos and determinants for requests and awards: an evaluation based on record-linkage between the Veneto Mesothelioma Register and the claims and compensations recorded by the National Insurance Institute (INAIL)]. Merler E; Bressan V; Bilato AM; Marinaccio A; Epidemiol Prev; 2011; 35(5-6):331-8. PubMed ID: 22166780 [TBL] [Abstract][Full Text] [Related]
31. Asbestos-related diseases. Algorithm for forensic pathological diagnosis. Ehrenreich T; Espinosa T; Langer AM; Rohl AN; Daum SM Am J Forensic Med Pathol; 1982 Dec; 3(4):315-21. PubMed ID: 6762088 [TBL] [Abstract][Full Text] [Related]
32. Asbestos exposure and related neoplasia. The 28 year experience of a major urban hospital. Hasan FM; Nash G; Kazemi H Am J Med; 1978 Oct; 65(4):649-54. PubMed ID: 707524 [TBL] [Abstract][Full Text] [Related]
36. Lump sum compensation for asbestos related lung disease. Williams T; Slade P; Raeburn J Thorax; 1998 Jul; 53(7):535. PubMed ID: 9797750 [No Abstract] [Full Text] [Related]
37. Apportionment in asbestos-related disease for purposes of compensation. Guidotti TL Ind Health; 2002 Oct; 40(4):295-311. PubMed ID: 12502232 [TBL] [Abstract][Full Text] [Related]
38. [Unrecognized occupational risk of pleural mesothelioma. The example of the Rhône-Alps region]. Harf R; Laval I; Davezies P; Prost G Rev Mal Respir; 1993; 10(5):453-8. PubMed ID: 8256032 [TBL] [Abstract][Full Text] [Related]
39. [Pleural and parenchymal lung diseases from asbestos exposure. CT diagnosis]. Polverosi R; Vigo M; Citton O Radiol Med; 2000 Nov; 100(5):326-31. PubMed ID: 11213409 [TBL] [Abstract][Full Text] [Related]
40. Diseases associated with the inhalation of asbestos dust. Davies CN Arh Hig Rada Toksikol; 1986 Jun; 37(2):253-74. PubMed ID: 3297003 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]